The Quest for a Vaccine Against Coccidioidomycosis: A Neglected Disease of the Americas.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

1. Intent to Accept a Valley Fever Vaccine for Humans and Dogs and Factors Influencing Intended Uptake: A Cross-Sectional Survey in Two Endemic Regions.Journal of fungi (Basel, Switzerland) · 2026
   Article
2. Coccidioidomycosis: a growing global concern.The Journal of antimicrobial chemotherapy · 2025
   Review
3. A Single-center Experience of Coccidioides Meningitis in Immunocompetent Patients: Case Series and Literature Review.Open forum infectious diseases · 2024
   Article
4. Challenges to Implementing a Vaccine for Coccidioidomycosis.Open forum infectious diseases · 2024
   Article
5. The Host Response to Coccidioidomycosis.Journal of fungi (Basel, Switzerland) · 2024
   Review
6. A Recombinant Multivalent Vaccine (rCpa1) Induces Protection for C57BL/6 and HLA Transgenic Mice against Pulmonary Infection with Both Species ofVaccines · 2024
   Article
7. Harnessing the Immune Response to Fungal Pathogens for Vaccine Development.Annual review of microbiology · 2022
   Review
8. Current Landscape of Coccidioidomycosis.Journal of fungi (Basel, Switzerland) · 2022
   Review
9. Δcps1 vaccine protects dogs against experimentally induced coccidioidomycosis.Vaccine · 2021
   Article
10. Clinical and Economic Burden of Valley Fever in Arizona: An Incidence-Based Cost-of-Illness Analysis.Open forum infectious diseases · 2021
    Article
11. Coccidioidomycosis in Brazil: Historical Challenges of a Neglected Disease.Journal of fungi (Basel, Switzerland) · 2021
    Review
12. Coccidioidomycosis: Changing Concepts and Knowledge Gaps.Journal of fungi (Basel, Switzerland) · 2020
    Review
13. CARD9-Associated Dectin-1 and Dectin-2 Are Required for Protective Immunity of a Multivalent Vaccine againstJournal of immunology (Baltimore, Md. : 1950) · 2020
    Article
14. Update on Coccidioidomycosis in the United States and Beyond.Global pediatric health · 2020
    Review
15. Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response.Frontiers in immunology · 2020
    Review
16. New Developments in Bacterial, Viral, and Fungal Cutaneous Infections.Current dermatology reports · 2020
    Review
17. Coccidioidomycosis: Epidemiology, Fungal Pathogenesis, and Therapeutic Development.Current tropical medicine reports · 2019
    Article
18. A review of innate and adaptive immunity to coccidioidomycosis.Medical mycology · 2019
    Review
19. Coccidioidomycosis: What a long strange trip it's been.Medical mycology · 2019
    Review
20. The Rise ofFrontiers in immunology · 2019
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as